Health and Me

Tanya Dutt

Mum Dies Minutes After Routine CT Scan For Toothache She Couldn't Get Treated, Partner Urges Not Delay Health Check-ups

What was supposed to be a routine hospital visit to deal with an persistent toothache resulted in a catastrophic and fatal allergic reaction for County Durham, England's 34-year-old Leigh Rodgers. Leigh went for medical attention early in March 2024 after two weeks of living with unbearable toothache and having trouble finding a dentist appointment. When her pain worsened, spreading to her neck and chest, physicians became worried about a life-threatening, unusual bacterial infection—Ludwig's angina—and had her undergo a CT scan to eliminate it.

Yet, just 90 minutes after the scan, Leigh suffered anaphylactic shock—a catastrophic allergic reaction to the contrast dye administered before the imaging—and sadly died. Her premature death has now raised new debates about patient awareness, risks of contrast dye, and emergency dental care gaps.

<h2>What are Contrast Dye Reactions?</h2>

CT scans, particularly when employed to evaluate infections or internal injury, usually include injecting a contrast dye. The contrast dye, commonly iodine, makes organs and tissues more visible during the test. While a necessity for making accurate diagnoses, these contrast medications carry a potential for adverse reaction.

Based on numerous medical studies and health warnings, severe allergic responses to contrast medium are seen in less than 1% of patients. While the majority of people can safely take the dye, susceptible persons can have reactions from mild (nausea, skin rash, metallic taste) to severe (difficulty in breathing, hypotension, convulsions).

In Leigh's situation, even though she was never diagnosed with previous dye allergies, her body responded lethally within minutes of contact. The tragedy is not just the reaction but the timing as well—had she received prompt dental attention, the CT scan would never have been required.

Ludwig's angina, as rare as it is, is a serious illness caused by infections from bacteria starting in the mouth or jaw. It can rapidly swell the throat and neck and block the airway. Due to its severity and deadly risk, physicians are usually cautious to the point of overcautiousness if symptoms indicate infection spread as a possibility.

Leigh's symptoms—crescendo pain, edema, and chest pain—paralleled early signs of Ludwig's angina that led to ordering the CT scan. The infection was eventually discounted by the CT scan, yet by this point, the dye had already been injected.

Leigh's tearful mother, Pam Rodgers, has been vocal about what happened to her daughter. She is adamant that the UK's clogged-up dental health care system had something to do with Leigh's fatal accident. "If she'd been able to have a dental appointment, she wouldn't be dead," she said. Pam has also questioned informed consent and whether Leigh was properly informed of the dangers involved in the CT scan.

Her comment reveals something of an oft-forgotten problem—patients receiving diagnostic scans may not always be properly informed about the dangers of contrast agents, particularly in high-pressure emergency environments.

Pam continued, "There's nothing to prevent them from distributing a leaflet to describe the risks… I want people to know about risks associated with contrast media and problems with the NHS."

Leigh's case also highlights an increasing public healthcare crisis: the unavailability of timely access to dental treatment. Her partner gave evidence during the inquest that Leigh had attempted multiple times to obtain a dentist appointment within two weeks but failed because of long waiting lists and system delays.

The inquest concluded that Leigh died from an anaphylactic reaction to contrast dye after attending the hospital for symptoms linked to a suspected tooth abscess. Despite the CT scan revealing no signs of Ludwig’s angina, her allergic reaction progressed too rapidly for intervention.

The County Durham and Darlington NHS Foundation Trust issued a statement of condolences and confirmed that an internal review had been conducted, and the findings had been given to the family. "We are ensuring that the lessons learned from this report are embedded across the trust to improve our services," the statement said.

<h2>Warning Signs and What You Need to Know About Contrast Dye Allergies</h2>

Although uncommon, reactions to contrast dye cannot be ignored, particularly for those with existing conditions like kidney disease, heart disease, asthma, or allergies. The NHS advises patients to be observed for a minimum of 30 minutes after the scan if contrast is administered. Worrying symptoms are:

<ul><li>Breathlessness</li><li>Hives or flushing of skin</li><li>Swelling of lips or throat</li><li>Vomiting</li><li>Dizziness or fits</li></ul>

Patients with a history of reaction should always reveal such a history prior to imaging procedures. In others, pre-treatment with corticosteroids or antihistamines can be employed to reduce risks.

Leigh Rodgers' tale is a chilling reminder of how uncommon complications can have devastating consequences. It also underscores the imperative need for improved communication between patients and healthcare providers, particularly for risk disclosures in emergency situations.

This event also supports the need to address systemic shortcomings in first-level healthcare services such as dentistry, where access delays can result in higher-risk, more costly interventions. For patients, it is a reminder to be proactive in asking questions prior to any diagnostic procedure, being aware of possible risks, and being an advocate for themselves when normal care is not available.

In Leigh's memory, her family wishes that this tragedy will spur change—how patients are told things, how soon they can receive critical care, and how infrequent medical risks are disclosed and monitored in real time.

Health Conditions A-Z

health

health news

ct scan allergy death

contrast dye reaction

leigh rodgers case

dental care delays uk

anaphylactic shock from scan

nhs patient safety

ludwig’s angina misdiagnosis

Kerala Student Tests Positive For H1N1, 3 More Showing Symptoms -Top Signs And Symptoms To Note

The Dream Of 'Super Breed Babies' Is Becoming A Reality In Silicon Valley, Babies Are Now Not Just Born, But Selected

'Three-Parent-Baby' Technique: How UK Is Making Healthy Babies With DNA From Three People To Avoid Genetic Mitochondrial Disease

Health News

Health Benefits of Walking Backwards

No Eggs? Egg-Alternatives You Can Add To Your Diet

Savory And Smart Ways To Add Broccoli To Your Diet

Calorie Burning Habits That Can Help You Shed Extra Pounds

Yoga Poses That Can Help With Bloating

Fiber-Rich Oatmeal Dishes You Can Have For Breakfast

Signs You Must Visit A Doctor For Your Back Pain

Avocado Meal Prep Ideas To Increase Healthy Fat In Your Diet

Arm Exercises You Can Do At Home

Quick-Office Lunches That Can Keep You Full-Longer

How Increased Screen Time Affects Children's Health

Homemade Recipe To Make Protein-Rich Pancakes With Healthy Alternatives

Push-Up Variations You Can Do At Home

Common Mistakes Running Mistakes People Make

Low-Calorie Foods That Keep You Full For Long

Yoga Poses That Help You Get Rid Of Back Pain

Natural Ways To Increase Protein In Your Diet

Managing Excessive Daytime Sleepiness – Tips To Try

How Much Protein Is Too Much?

High Fiber Indian Foods You Should Try

10 Easy Ways To Boost Daily Fiber Intake

Adding Walnut Oil To Your Diet? Benefits You Should Know

Drinks That Soothe Headaches And Migraines

Waist Exercises For More Toned Belly

This Is How Stress Affects Your Heart

Does Digital ‘Brain Rot’ Really Affect Your Health?

Dishes With Fermented Foods To Eat For Your Gut Health

Yoga Poses That Stimulate Good Bowel Health

Weekend Warrior Exercises For Full Body Movement

Weekend Meal Prep Ideas That Will Last You A Weekend

Easy Homemade Healthy Dishes For Long Afternoons

Silent Walking: Mental Health Booster That Keeps You Fit

Dumbbell Exercises You Can Do At Home

These Foods Are Keeping You Awake At Night

Ways to Manage Sugar Cravings

Your Body Doesn’t Want You To Lose Weight – Here's It Resists

High-Protein No Cook Dishes You Should Try

Yoga Poses That Aid In Digestion

Low Calorie Dinner Options For Weight Loss

Cardiac Arrest Vs. Heart Attack: Difference Explained Under 60 Seconds

What was supposed to be a routine hospital visit to deal with an persistent toothache resulted in a catastrophic and fatal allergic reaction for County Durham, England's 34-year-old Leigh Rodgers. Leigh went for medical attention early in March 2024 after two weeks of living with unbearable toothache and having trouble finding a dentist appointment. When her pain worsened, spreading to her neck and chest, physicians became worried about a life-threatening, unusual bacterial infection—Ludwig's angina—and had her undergo a CT scan to eliminate it.Yet, just 90 minutes after the scan, Leigh suffered anaphylactic shock—a catastrophic allergic reaction to the contrast dye administered before the imaging—and sadly died. Her premature death has now raised new debates about patient awareness, risks of contrast dye, and emergency dental care gaps.What are Contrast Dye Reactions?CT scans, particularly when employed to evaluate infections or internal injury, usually include injecting a contrast dye. The contrast dye, commonly iodine, makes organs and tissues more visible during the test. While a necessity for making accurate diagnoses, these contrast medications carry a potential for adverse reaction.Based on numerous medical studies and health warnings, severe allergic responses to contrast medium are seen in less than 1% of patients. While the majority of people can safely take the dye, susceptible persons can have reactions from mild (nausea, skin rash, metallic taste) to severe (difficulty in breathing, hypotension, convulsions).In Leigh's situation, even though she was never diagnosed with previous dye allergies, her body responded lethally within minutes of contact. The tragedy is not just the reaction but the timing as well—had she received prompt dental attention, the CT scan would never have been required.Ludwig's angina, as rare as it is, is a serious illness caused by infections from bacteria starting in the mouth or jaw. It can rapidly swell the throat and neck and block the airway. Due to its severity and deadly risk, physicians are usually cautious to the point of overcautiousness if symptoms indicate infection spread as a possibility.Leigh's symptoms—crescendo pain, edema, and chest pain—paralleled early signs of Ludwig's angina that led to ordering the CT scan. The infection was eventually discounted by the CT scan, yet by this point, the dye had already been injected.Leigh's tearful mother, Pam Rodgers, has been vocal about what happened to her daughter. She is adamant that the UK's clogged-up dental health care system had something to do with Leigh's fatal accident. "If she'd been able to have a dental appointment, she wouldn't be dead," she said. Pam has also questioned informed consent and whether Leigh was properly informed of the dangers involved in the CT scan.Her comment reveals something of an oft-forgotten problem—patients receiving diagnostic scans may not always be properly informed about the dangers of contrast agents, particularly in high-pressure emergency environments.Pam continued, "There's nothing to prevent them from distributing a leaflet to describe the risks… I want people to know about risks associated with contrast media and problems with the NHS."Leigh's case also highlights an increasing public healthcare crisis: the unavailability of timely access to dental treatment. Her partner gave evidence during the inquest that Leigh had attempted multiple times to obtain a dentist appointment within two weeks but failed because of long waiting lists and system delays.The inquest concluded that Leigh died from an anaphylactic reaction to contrast dye after attending the hospital for symptoms linked to a suspected tooth abscess. Despite the CT scan revealing no signs of Ludwig’s angina, her allergic reaction progressed too rapidly for intervention.The County Durham and Darlington NHS Foundation Trust issued a statement of condolences and confirmed that an internal review had been conducted, and the findings had been given to the family. "We are ensuring that the lessons learned from this report are embedded across the trust to improve our services," the statement said.Warning Signs and What You Need to Know About Contrast Dye AllergiesAlthough uncommon, reactions to contrast dye cannot be ignored, particularly for those with existing conditions like kidney disease, heart disease, asthma, or allergies. The NHS advises patients to be observed for a minimum of 30 minutes after the scan if contrast is administered. Worrying symptoms are:BreathlessnessHives or flushing of skinSwelling of lips or throatVomitingDizziness or fitsPatients with a history of reaction should always reveal such a history prior to imaging procedures. In others, pre-treatment with corticosteroids or antihistamines can be employed to reduce risks.Leigh Rodgers' tale is a chilling reminder of how uncommon complications can have devastating consequences. It also underscores the imperative need for improved communication between patients and healthcare providers, particularly for risk disclosures in emergency situations.This event also supports the need to address systemic shortcomings in first-level healthcare services such as dentistry, where access delays can result in higher-risk, more costly interventions. For patients, it is a reminder to be proactive in asking questions prior to any diagnostic procedure, being aware of possible risks, and being an advocate for themselves when normal care is not available.In Leigh's memory, her family wishes that this tragedy will spur change—how patients are told things, how soon they can receive critical care, and how infrequent medical risks are disclosed and monitored in real time.

mum dies minutes after routine ct scan for toothache she couldn't get treated, partner urges not delay health check-ups

Ishita Roy

Parenting

the dream of 'super breed babies' is becoming a reality in silicon valley, babies are now not just born, but selected

Nutrition

It’s In Cheese, Soy And Semen! This Natural Compound Can Help People Live Longer

it’s in cheese, soy and semen! this natural compound can help people live longer

Health & Wellness

Vaccines For Children Pose No Threat To Their Heart Health Or Other Health Issues: Study

vaccines for children pose no threat to their heart health or other health issues: study

1 In 4 Indian Couples Are Overweight, Finds ICMR; How Obesity Is Now Becoming A Relationship Problem?

1 in 4 indian couples are overweight, finds icmr; how obesity is now becoming a relationship problem?

<span>Mitochondrial Disease</span>: In a groundbreaking development in reproductive medicine, researchers in the U.K. announced that eight healthy babies have been born using an experimental technique involving DNA from three people. 

The method was developed to help prevent mothers from passing on devastating mitochondrial diseases to their children — conditions that can lead to seizures, muscle weakness, organ failure, developmental delays, and even death.

This scientific milestone was detailed in a study published in the New England Journal of Medicine on Wednesday. 

Experts from Newcastle University in the U.K. and Monash University in Australia conducted the procedures, which used a technique known as mitochondrial donation treatment. The technique replaces faulty mitochondria, which are the tiny energy-producing structures in cells, with healthy ones from a donor.

While most of our DNA is stored in the nucleus of our cells and inherited equally from both parents, a small but vital portion resides in the mitochondria and comes solely from the mother. Mutations in this mitochondrial DNA can lead to serious, and often fatal, genetic disorders in children.

During the in vitro fertilization (IVF) process, it is sometimes possible to detect these mutations early. However, in rare cases, such mutations go undetected — which is where mitochondrial donation becomes important.

In this method, scientists transfer the nuclear DNA from the mother's egg or embryo into a donor egg or embryo that contains healthy mitochondria but has had its own nuclear DNA removed. The resulting embryo contains nuclear DNA from the parents and mitochondrial DNA from a donor — essentially, the genetic input of three people.

<h4>A Scientific First Made Possible by Law</h4>

The U.K. became the first country in the world to legalize mitochondrial donation for clinical use in 2016, after years of ethical and scientific debates. Australia has also approved its use. However, the U.S. still prohibits any clinical research involving genetic modification of human embryos that could be inherited.

“This marks an important milestone,” said Dr. Zev Williams, director of the Columbia University Fertility Center in New York, who was not involved in the study. “Expanding the range of reproductive options will empower more couples to pursue safe and healthy pregnancies.”

As of now, 35 couples have been approved by the U.K.’s fertility regulator to undergo the procedure. Of the 22 patients treated in the reported study, eight babies have been born, and one more woman is still pregnant. Most of the children appear to be free of mitochondrial disease, though one child was found to have a slightly higher-than-expected level of abnormal mitochondria. Experts say this level is not currently cause for concern but will require monitoring.

Despite the involvement of a third person, scientists emphasize that the genetic material from the donor is minimal. Dr. Robin Lovell-Badge, a stem cell expert at the Francis Crick Institute, noted that the donor’s mitochondrial DNA makes up less than 1% of the baby’s total genetic makeup — not enough to influence personal traits like appearance or personality.

“In fact, if you had a bone marrow transplant, you would carry much more of another person’s DNA,” he explained.

<h4>Hope for Families, But Questions Remain</h4>

The technology remains controversial in some circles. Critics warn that the long-term effects of such genetic manipulation are still unknown and could have unintended consequences for future generations. In the U.S., Congress has repeatedly blocked any government funding or approval of similar research.

Still, for many families, the promise of avoiding a life-threatening diagnosis is worth the risk.

Liz Curtis, whose daughter Lily died of mitochondrial disease in 2006 at just eight months old, now advocates for awareness and research. She founded the Lily Foundation in her daughter's memory and supports the work being done at Newcastle University.

Curtis said the diagnosis devastated her family. “Nobody could tell us what it was or how it would affect Lily. It was just a waiting game,” she recalled. “This new technique gives hope to families who’ve had very little of it.”

As science and ethics continue to evolve, the three-parent baby technique stands as a powerful, if complex, step forward in preventing inherited genetic illness.

mitochondrial disease

healthn ews

uk healthnews

health news UK

three parent baby

parenting

Mitochondrial Disease: In a groundbreaking development in reproductive medicine, researchers in the U.K. announced that eight healthy babies have been born using an experimental technique involving DNA from three people. The method was developed to help prevent mothers from passing on devastating mitochondrial diseases to their children — conditions that can lead to seizures, muscle weakness, organ failure, developmental delays, and even death.This scientific milestone was detailed in a study published in the New England Journal of Medicine on Wednesday. Experts from Newcastle University in the U.K. and Monash University in Australia conducted the procedures, which used a technique known as mitochondrial donation treatment. The technique replaces faulty mitochondria, which are the tiny energy-producing structures in cells, with healthy ones from a donor.What Is Mitochondrial DNA?While most of our DNA is stored in the nucleus of our cells and inherited equally from both parents, a small but vital portion resides in the mitochondria and comes solely from the mother. Mutations in this mitochondrial DNA can lead to serious, and often fatal, genetic disorders in children.During the in vitro fertilization (IVF) process, it is sometimes possible to detect these mutations early. However, in rare cases, such mutations go undetected — which is where mitochondrial donation becomes important.In this method, scientists transfer the nuclear DNA from the mother's egg or embryo into a donor egg or embryo that contains healthy mitochondria but has had its own nuclear DNA removed. The resulting embryo contains nuclear DNA from the parents and mitochondrial DNA from a donor — essentially, the genetic input of three people.A Scientific First Made Possible by LawThe U.K. became the first country in the world to legalize mitochondrial donation for clinical use in 2016, after years of ethical and scientific debates. Australia has also approved its use. However, the U.S. still prohibits any clinical research involving genetic modification of human embryos that could be inherited.“This marks an important milestone,” said Dr. Zev Williams, director of the Columbia University Fertility Center in New York, who was not involved in the study. “Expanding the range of reproductive options will empower more couples to pursue safe and healthy pregnancies.”As of now, 35 couples have been approved by the U.K.’s fertility regulator to undergo the procedure. Of the 22 patients treated in the reported study, eight babies have been born, and one more woman is still pregnant. Most of the children appear to be free of mitochondrial disease, though one child was found to have a slightly higher-than-expected level of abnormal mitochondria. Experts say this level is not currently cause for concern but will require monitoring.A Tiny Donor FootprintDespite the involvement of a third person, scientists emphasize that the genetic material from the donor is minimal. Dr. Robin Lovell-Badge, a stem cell expert at the Francis Crick Institute, noted that the donor’s mitochondrial DNA makes up less than 1% of the baby’s total genetic makeup — not enough to influence personal traits like appearance or personality.“In fact, if you had a bone marrow transplant, you would carry much more of another person’s DNA,” he explained.Hope for Families, But Questions RemainThe technology remains controversial in some circles. Critics warn that the long-term effects of such genetic manipulation are still unknown and could have unintended consequences for future generations. In the U.S., Congress has repeatedly blocked any government funding or approval of similar research.Still, for many families, the promise of avoiding a life-threatening diagnosis is worth the risk.Liz Curtis, whose daughter Lily died of mitochondrial disease in 2006 at just eight months old, now advocates for awareness and research. She founded the Lily Foundation in her daughter's memory and supports the work being done at Newcastle University.Curtis said the diagnosis devastated her family. “Nobody could tell us what it was or how it would affect Lily. It was just a waiting game,” she recalled. “This new technique gives hope to families who’ve had very little of it.”As science and ethics continue to evolve, the three-parent baby technique stands as a powerful, if complex, step forward in preventing inherited genetic illness.

'three-parent-baby' technique: how uk is making healthy babies with dna from three people to avoid genetic mitochondrial disease

Forget Blood Tests Now Dogs Can Sniff Out Parkinson’s Before Symptoms Appear

What's The Confusion! Why Most Women Don’t Know When To Start Mammogram Screenings?

what's the confusion! why most women don’t know when to start mammogram screenings?

AIIMS Oncologist Reveals Why Oral Health Could Tip The Scale In Cancer Survival In Southeast Asia

lancet study reveals why oral health could tip the scale in cancer survival in southeast asia

New WHO Guidelines Reveal The Blueprint To Manage Dengue, Chikungunya, Yellow Fever And Zika

new who guidelines reveal the blueprint to manage dengue, chikungunya, yellow fever and zika

Parkinson’s disease is notoriously difficult to diagnose early. Most patients aren’t identified until visible motor symptoms—tremors, stiffness, and slowness—are already affecting their lives. By that point, neurodegeneration has usually been ongoing for years. But a new study out of the UK could be a game-changer: specially trained dogs have proven they can detect Parkinson’s disease with remarkable accuracy—just by sniffing skin swabs.

In controlled clinical trials, two dogs achieved sensitivities between 70–80% and specificities exceeding 90% in detecting Parkinson’s disease from the scent of sebum, an oily substance secreted by the skin. That’s not just impressive—it rivals many of today’s most advanced diagnostic tools.

What exactly are dogs smelling? Turns out, Parkinson’s isn’t just a neurological disease. It also affects how the body metabolizes and produces oils on the skin. These changes lead to a unique profile of volatile organic compounds (VOCs)—essentially odor molecules—that trained dogs can detect.

The research builds on previous anecdotal reports, including that of Joy Milne, a Scottish woman who famously detected a musky scent from her husband years before he was diagnosed with Parkinson’s. Scientists later confirmed that this scent wasn’t imaginary—it was chemically real. Dogs, with their 10,000x more sensitive noses, just happen to be better equipped than humans at picking it up.

Researchers at the Universities of Bristol and Manchester collaborated with <span>Medical Detection Dogs</span>, a UK-based charity, to test whether Parkinson’s has a detectable odor signature. They began with 10 dogs and narrowed it down to two standouts: a male Golden Retriever and a Labrador-Golden mix.

Over the course of 38 to 53 weeks, these dogs were trained using 205 cotton swab samples collected from patients' backs—some with Parkinson’s, others without. Dogs were rewarded when they correctly identified samples from individuals with the disease. Importantly, the study was double-blind: neither the trainers nor the researchers knew which swabs were which during testing, ensuring unbiased results.

When the final test arrived—100 brand-new samples the dogs had never sniffed before—the animals performed exceptionally well. One dog hit 70% sensitivity and 90% specificity, while the other clocked in at 80% sensitivity and an astounding 98% specificity.

For context, that level of performance is on par with several existing diagnostic tests and better than previous scent-based trials involving cancers or infections.

Currently, there’s no blood test or brain scan that definitively diagnoses Parkinson’s early. Clinicians rely on watching for physical symptoms, which means by the time you’re diagnosed, significant damage may have already occurred.

Detection dogs could change that. By identifying Parkinson’s via skin swabs—before symptoms show up—these animals could help start the treatment process earlier, potentially slowing disease progression or improving long-term outcomes.

It’s especially meaningful in rural or underserved areas, where neurologists and movement disorder specialists are harder to access. A non-invasive, rapid screening tool—even if it’s a dog—could fill critical gaps.

Parkinson’s patients often develop seborrheic dermatitis, a condition that increases the production of sebum. In those with Parkinson’s, this sebum is chemically different. Dogs can detect those changes.

This builds on previous studies which have shown that diseases like cancer, malaria, and even COVID-19 can subtly change the body’s scent signature. The nose—particularly a canine one—may be among the most overlooked diagnostic tools in medicine.

And while dogs won’t be showing up in every clinic just yet, the data they provide is already helping researchers design electronic noses—devices that mimic canine olfaction and can detect VOCs in human sweat, sebum, or breath.

<h2>Are There Any Limitations Of This Kind Of Detection?</h2>

Of course, the idea of using dogs as diagnostic tools has its limits. Training a single dog takes nearly a year and is resource-intensive. Only a small number of dogs are temperamentally suited to this kind of highly focused scent work. And the study still doesn’t explain why some Parkinson’s patients’ samples were easier for dogs to detect than others.

Researchers also emphasize that dogs would not replace neurologists—but they could be used as a pre-screening tool, flagging individuals who should undergo further clinical evaluation.

The dogs in this study worked only with drug-naive patients—those who hadn’t yet started medications—meaning the scent signature they detected wasn’t masked or altered by pharmaceutical treatment. Future research may explore whether medication changes a patient’s odor profile or affects detection accuracy.

<h2>How Will This Change the Future of Parkinson’s Diagnosis?</h2>

Quite possibly, if scientists can isolate the exact VOCs that signal Parkinson’s—and replicate what dogs detect with sensors or lab tests—we could one day have a rapid, affordable, and non-invasive way to diagnose the disease long before traditional symptoms show up.

That would mark a sea change in Parkinson’s treatment strategy: from managing symptoms to preemptively addressing the disease at its earliest, most treatable stage.

Until then, we may just need to trust our four-legged friends to lead the way—nose first.

Dogs are proving to be more than just loyal companions—they’re potentially medical detectives. With their powerful noses, they may soon help detect Parkinson’s earlier than ever before, offering hope for millions living with or at risk of the disease.

parkinsons disease diagnosis

dogs smell parkinsons

early detection parkinsons

medical detection dogs

sebum parkinsons scent

parkinsons skin odor

non invasive parkinsons test

Parkinson’s disease is notoriously difficult to diagnose early. Most patients aren’t identified until visible motor symptoms—tremors, stiffness, and slowness—are already affecting their lives. By that point, neurodegeneration has usually been ongoing for years. But a new study out of the UK could be a game-changer: specially trained dogs have proven they can detect Parkinson’s disease with remarkable accuracy—just by sniffing skin swabs.In controlled clinical trials, two dogs achieved sensitivities between 70–80% and specificities exceeding 90% in detecting Parkinson’s disease from the scent of sebum, an oily substance secreted by the skin. That’s not just impressive—it rivals many of today’s most advanced diagnostic tools.Does Parkinson’s Has a Scent?What exactly are dogs smelling? Turns out, Parkinson’s isn’t just a neurological disease. It also affects how the body metabolizes and produces oils on the skin. These changes lead to a unique profile of volatile organic compounds (VOCs)—essentially odor molecules—that trained dogs can detect.The research builds on previous anecdotal reports, including that of Joy Milne, a Scottish woman who famously detected a musky scent from her husband years before he was diagnosed with Parkinson’s. Scientists later confirmed that this scent wasn’t imaginary—it was chemically real. Dogs, with their 10,000x more sensitive noses, just happen to be better equipped than humans at picking it up.How The Dogs Were Trained?Researchers at the Universities of Bristol and Manchester collaborated with Medical Detection Dogs, a UK-based charity, to test whether Parkinson’s has a detectable odor signature. They began with 10 dogs and narrowed it down to two standouts: a male Golden Retriever and a Labrador-Golden mix.Over the course of 38 to 53 weeks, these dogs were trained using 205 cotton swab samples collected from patients' backs—some with Parkinson’s, others without. Dogs were rewarded when they correctly identified samples from individuals with the disease. Importantly, the study was double-blind: neither the trainers nor the researchers knew which swabs were which during testing, ensuring unbiased results.When the final test arrived—100 brand-new samples the dogs had never sniffed before—the animals performed exceptionally well. One dog hit 70% sensitivity and 90% specificity, while the other clocked in at 80% sensitivity and an astounding 98% specificity.For context, that level of performance is on par with several existing diagnostic tests and better than previous scent-based trials involving cancers or infections.Currently, there’s no blood test or brain scan that definitively diagnoses Parkinson’s early. Clinicians rely on watching for physical symptoms, which means by the time you’re diagnosed, significant damage may have already occurred.Detection dogs could change that. By identifying Parkinson’s via skin swabs—before symptoms show up—these animals could help start the treatment process earlier, potentially slowing disease progression or improving long-term outcomes.It’s especially meaningful in rural or underserved areas, where neurologists and movement disorder specialists are harder to access. A non-invasive, rapid screening tool—even if it’s a dog—could fill critical gaps.Parkinson’s patients often develop seborrheic dermatitis, a condition that increases the production of sebum. In those with Parkinson’s, this sebum is chemically different. Dogs can detect those changes.This builds on previous studies which have shown that diseases like cancer, malaria, and even COVID-19 can subtly change the body’s scent signature. The nose—particularly a canine one—may be among the most overlooked diagnostic tools in medicine.And while dogs won’t be showing up in every clinic just yet, the data they provide is already helping researchers design electronic noses—devices that mimic canine olfaction and can detect VOCs in human sweat, sebum, or breath.Are There Any Limitations Of This Kind Of Detection?Of course, the idea of using dogs as diagnostic tools has its limits. Training a single dog takes nearly a year and is resource-intensive. Only a small number of dogs are temperamentally suited to this kind of highly focused scent work. And the study still doesn’t explain why some Parkinson’s patients’ samples were easier for dogs to detect than others.Researchers also emphasize that dogs would not replace neurologists—but they could be used as a pre-screening tool, flagging individuals who should undergo further clinical evaluation.The dogs in this study worked only with drug-naive patients—those who hadn’t yet started medications—meaning the scent signature they detected wasn’t masked or altered by pharmaceutical treatment. Future research may explore whether medication changes a patient’s odor profile or affects detection accuracy.How Will This Change the Future of Parkinson’s Diagnosis?Quite possibly, if scientists can isolate the exact VOCs that signal Parkinson’s—and replicate what dogs detect with sensors or lab tests—we could one day have a rapid, affordable, and non-invasive way to diagnose the disease long before traditional symptoms show up.That would mark a sea change in Parkinson’s treatment strategy: from managing symptoms to preemptively addressing the disease at its earliest, most treatable stage.Until then, we may just need to trust our four-legged friends to lead the way—nose first.Dogs are proving to be more than just loyal companions—they’re potentially medical detectives. With their powerful noses, they may soon help detect Parkinson’s earlier than ever before, offering hope for millions living with or at risk of the disease.

forget blood tests now dogs can sniff out parkinson’s before symptoms appear

RFK Jr. And Trump Cabinet Want Psychedelics To Be Legal After FDA Shut Down; What This Means For The Controversial Drug?

RFK Jr. And Trump Cabinet Want Psychedelics To Be Legal After FDA Shut Down; What This Means For The Controversial Drug

Warning Letter Sent To Companies Selling Illegal Opioid Compound

warning letter sent to companies selling illegal opioid compound

Tara Moore Fails Doping Test, Handed 4-Year Ban—Follows Jannik Sinner in Doping Controversy Spotlight

after jannik sinner, tara moore makes news failing her doping test, resulting in a 4-year long ban

This Therapy Can Increase The Effectiveness Of GLP-1 Weight Loss Drugs  Among Postmenopausal Women

glp-1 weight loss drug effectiveness increases with this therapy in postmenopausal women: study

In a move that would have seemed unthinkable just a decade ago, a new presidential administration is placing psychedelics front and center in its health policy agenda. Health Secretary Robert F. Kennedy Jr. told Congress that psychedelic-assisted therapy—long stigmatized and sidelined—is on track for federal approval “within 12 months.”

That timeline stunned even long-time advocates. But it aligns with a wider political shift, not just in progressive strongholds but also in conservative territories like Texas. Former Trump officials including ex-Governor Rick Perry and Secretary of Veterans Affairs Doug Collins have expressed support for expanding access to psychedelics for treating PTSD, depression, and addiction.

The timing is no accident. The U.S. Food and Drug Administration (FDA) recently dealt a heavy blow to advocates by rejecting MDMA-assisted therapy for PTSD, citing concerns over research integrity. The decision was a major setback for the psychedelic movement—but it may also have sparked a political counter-response.

MDMA, also known as ecstasy, had long been the frontrunner in the race to integrate psychedelics into clinical medicine. The Multidisciplinary Association for Psychedelic Studies (MAPS), which backed MDMA research for decades, had hoped for a groundbreaking FDA approval this year.

Instead, FDA advisors voted overwhelmingly against it, criticizing data collection methods, researcher bias, and missing adverse event reports. One panelist described the trial environment as bordering on “cult-like.” Critics argued that while results appeared promising, the data lacked scientific rigor.

The agency hasn’t entirely shut the door on MDMA, but it's clear that any future approval will come with strict conditions—or require new clinical trials entirely.

Rather than retreating, psychedelic advocates now seem to be finding powerful allies. Kennedy’s endorsement of psychedelic therapies stems in part from personal experience—he’s spoken openly about family members and friends who found healing through these substances.

Meanwhile, Rick Perry and other Republican figures are pushing forward with state-level projects that bypass the slow-moving federal process. Texas recently approved $50 million to fund research into ibogaine, a powerful and controversial psychedelic derived from a West African plant.

Ibogaine remains a Schedule I substance, in the same legal category as heroin. But veterans and policymakers in Texas are betting on it to address the state’s opioid crisis and support those suffering from war-related trauma.

“It’s not just red states or blue states anymore—it’s veterans, families, people from across the spectrum who are saying: what we’re doing isn’t working,” said Bryan Hubbard, co-founder of Americans for Ibogaine.

<h2>What is The Ibogaine Experiment?</h2>

Ibogaine is not your typical psychedelic. While small studies suggest it may reset the brain’s reward system and break addictive cycles, it’s also known for severe side effects—including potentially lethal heart arrhythmias.

Veterans like Marcus Capone say it changed their lives. Capone, a former Navy SEAL, describes his first ibogaine experience as “a complete purge.” After years of therapy and medication, one session left him with “no more anxiety, no more depression.”

His nonprofit, VETS, has already sent over 1,000 veterans abroad for psychedelic treatment. But federal officials remain cautious. Former NIDA director Nora Volkow acknowledged ibogaine’s promise but warned it “would be dead in the water” for FDA approval in its current form due to toxicity risks.

Still, the National Institutes of Health is now supporting development of synthetic ibogaine analogs—evidence that even federal agencies are evolving.

<h2>Fast-Tracking Psychedelic Drug Approval—At What Cost?</h2>

FDA commissioner Marty Makary, who reports to RFK Jr., recently announced efforts to accelerate drug approvals that serve “American health interests.” One proposed framework could shrink the FDA’s review process from six months to just one.

Makary has also floated the idea of relaxing placebo-controlled trial requirements—controversial in psychedelic research because participants often know if they received the real drug. That change could open the door for faster results, but it also raises concerns about scientific integrity.

Critics like Yale psychiatrist Philip Corlett are sounding the alarm. “The public is ahead of the science right now,” he warns. “If RFK and others are serious, they should stick to the benchmarks of clinical research. Otherwise, this could backfire.”

The future of MDMA therapy is uncertain. FDA regulators could override the advisory panel’s vote and approve the drug with new safeguards, such as risk evaluation and mitigation strategies (REMS). Another possibility: conditional approval with a requirement for post-market research.

But there’s also a chance the drug could be shelved, at least temporarily, while Lykos—the company behind the MDMA trials—regroups and launches a new study. That could delay approval by years.

“The hope was that if we did the science right, the data would speak for itself,” said trial investigator Ingmar Gorman. “But that’s not how it played out.”

The psychedelic renaissance now finds itself in a paradox: increasingly mainstream and bipartisan in political circles, but still fragile in the eyes of regulatory science.

States like Texas and Oregon are forging ahead. Veterans and nonprofits are doing the groundwork. And the federal government, under a high-profile and controversial health secretary, appears willing to fast-track approval processes but speed and politics won’t substitute for rigorous evidence. If the next wave of psychedelic approvals is rushed or mishandled, it could risk discrediting therapies that millions of patients might one day benefit from.

rfk jr psychedelics

mdma fda rejection

ibogaine research texas

psychedelic therapy approval

trump officials psychedelics

mdma ptsd treatment

psychedelic drug policy

In a move that would have seemed unthinkable just a decade ago, a new presidential administration is placing psychedelics front and center in its health policy agenda. Health Secretary Robert F. Kennedy Jr. told Congress that psychedelic-assisted therapy—long stigmatized and sidelined—is on track for federal approval “within 12 months.”That timeline stunned even long-time advocates. But it aligns with a wider political shift, not just in progressive strongholds but also in conservative territories like Texas. Former Trump officials including ex-Governor Rick Perry and Secretary of Veterans Affairs Doug Collins have expressed support for expanding access to psychedelics for treating PTSD, depression, and addiction.The timing is no accident. The U.S. Food and Drug Administration (FDA) recently dealt a heavy blow to advocates by rejecting MDMA-assisted therapy for PTSD, citing concerns over research integrity. The decision was a major setback for the psychedelic movement—but it may also have sparked a political counter-response.MDMA, also known as ecstasy, had long been the frontrunner in the race to integrate psychedelics into clinical medicine. The Multidisciplinary Association for Psychedelic Studies (MAPS), which backed MDMA research for decades, had hoped for a groundbreaking FDA approval this year.Instead, FDA advisors voted overwhelmingly against it, criticizing data collection methods, researcher bias, and missing adverse event reports. One panelist described the trial environment as bordering on “cult-like.” Critics argued that while results appeared promising, the data lacked scientific rigor.The agency hasn’t entirely shut the door on MDMA, but it's clear that any future approval will come with strict conditions—or require new clinical trials entirely.Rather than retreating, psychedelic advocates now seem to be finding powerful allies. Kennedy’s endorsement of psychedelic therapies stems in part from personal experience—he’s spoken openly about family members and friends who found healing through these substances.Meanwhile, Rick Perry and other Republican figures are pushing forward with state-level projects that bypass the slow-moving federal process. Texas recently approved $50 million to fund research into ibogaine, a powerful and controversial psychedelic derived from a West African plant.Ibogaine remains a Schedule I substance, in the same legal category as heroin. But veterans and policymakers in Texas are betting on it to address the state’s opioid crisis and support those suffering from war-related trauma.“It’s not just red states or blue states anymore—it’s veterans, families, people from across the spectrum who are saying: what we’re doing isn’t working,” said Bryan Hubbard, co-founder of Americans for Ibogaine.What is The Ibogaine Experiment?Ibogaine is not your typical psychedelic. While small studies suggest it may reset the brain’s reward system and break addictive cycles, it’s also known for severe side effects—including potentially lethal heart arrhythmias.Veterans like Marcus Capone say it changed their lives. Capone, a former Navy SEAL, describes his first ibogaine experience as “a complete purge.” After years of therapy and medication, one session left him with “no more anxiety, no more depression.”His nonprofit, VETS, has already sent over 1,000 veterans abroad for psychedelic treatment. But federal officials remain cautious. Former NIDA director Nora Volkow acknowledged ibogaine’s promise but warned it “would be dead in the water” for FDA approval in its current form due to toxicity risks.Still, the National Institutes of Health is now supporting development of synthetic ibogaine analogs—evidence that even federal agencies are evolving.Fast-Tracking Psychedelic Drug Approval—At What Cost?FDA commissioner Marty Makary, who reports to RFK Jr., recently announced efforts to accelerate drug approvals that serve “American health interests.” One proposed framework could shrink the FDA’s review process from six months to just one.Makary has also floated the idea of relaxing placebo-controlled trial requirements—controversial in psychedelic research because participants often know if they received the real drug. That change could open the door for faster results, but it also raises concerns about scientific integrity.Critics like Yale psychiatrist Philip Corlett are sounding the alarm. “The public is ahead of the science right now,” he warns. “If RFK and others are serious, they should stick to the benchmarks of clinical research. Otherwise, this could backfire.”What Happens to MDMA Now?The future of MDMA therapy is uncertain. FDA regulators could override the advisory panel’s vote and approve the drug with new safeguards, such as risk evaluation and mitigation strategies (REMS). Another possibility: conditional approval with a requirement for post-market research.But there’s also a chance the drug could be shelved, at least temporarily, while Lykos—the company behind the MDMA trials—regroups and launches a new study. That could delay approval by years.“The hope was that if we did the science right, the data would speak for itself,” said trial investigator Ingmar Gorman. “But that’s not how it played out.”The psychedelic renaissance now finds itself in a paradox: increasingly mainstream and bipartisan in political circles, but still fragile in the eyes of regulatory science.States like Texas and Oregon are forging ahead. Veterans and nonprofits are doing the groundwork. And the federal government, under a high-profile and controversial health secretary, appears willing to fast-track approval processes but speed and politics won’t substitute for rigorous evidence. If the next wave of psychedelic approvals is rushed or mishandled, it could risk discrediting therapies that millions of patients might one day benefit from.

rfk jr. and trump cabinet want psychedelics to be legal after fda shut down; what this means for the controversial drug?

About Us

Contact Us

Terms & Conditions

Company

Health and Me is a premium website with content written and curated to function as a handbook for all Health concerns.

Mum Dies Minutes After Routine CT Scan For Toothache She Couldn't Get Treated, Partner Urges Not Delay Health Check-ups

Quick Stories

Kerala Student Tests Positive For H1N1, 3 More Showing Symptoms -Top Signs And Symptoms To Note

'Three-Parent-Baby' Technique: How UK Is Making Healthy Babies With DNA From Three People To Avoid Genetic Mitochondrial Disease

Forget Blood Tests Now Dogs Can Sniff Out Parkinson’s Before Symptoms Appear

Health Conditions A-Z

Kerala Student Tests Positive For H1N1, 3 More Showing Symptoms -Top Signs And Symptoms To Note

The Dream Of 'Super Breed Babies' Is Becoming A Reality In Silicon Valley, Babies Are Now Not Just Born, But Selected

'Three-Parent-Baby' Technique: How UK Is Making Healthy Babies With DNA From Three People To Avoid Genetic Mitochondrial Disease